Skip to main content

Donald Trump on Pharmaceutical Investments and Drug Price Reductions

New York PostNovember 6, 202511 min2,060 views
38 connections·37 entities in this video→

Pharmaceutical Price Reductions

  • πŸ’‘ President Trump announced that Eli Lilly and Novo Nordisk have agreed to offer their popular GLP-1 weight loss drugs, Zepbound and Wegovy, at drastic discounts for American patients.
  • 🎯 The agreement aims to reduce the monthly cost of Zepbound from $1,350 to $250, and Wegovy from $1,080 to $346.
  • πŸš€ Future oral GLP-1 weight loss drugs are expected to be sold at no more than $149 per month.
  • πŸ’° Medicare and Medicaid will now cover these weight loss drugs, with co-pays for Medicare patients as low as $50.
  • πŸ“ˆ Other pharmaceutical companies like Pfizer, AstraZeneca, and EMD Serono have also agreed to lower prices for American patients.

Most Favored Nations Pricing

  • 🌍 Trump highlighted the disparity where Americans pay significantly more for drugs than patients in other countries, citing instances of paying 520% more for Zepbound and 1,400% more for Wegovy than in Europe.
  • βš–οΈ An executive order on most favored nations drug pricing aims to ensure Americans pay no more than the lowest price offered globally.
  • 🀝 Eli Lilly and Novo Nordisk will also provide all their other medications to Medicaid at most favored nations prices.

Domestic Manufacturing Investments

  • πŸ‡ΊπŸ‡Έ Eli Lilly is investing $27 billion and Novo Nordisk is investing $10 billion in the U.S. for domestic manufacturing facilities.
  • 🏭 These investments are part of a larger trend of significant investments in the United States, with total investments anticipated to exceed $21 trillion this year.
  • ⚠️ Trump emphasized the importance of tariffs in encouraging domestic production and preventing reliance on foreign countries for medicine, referencing the need to reshore manufacturing that was previously outsourced to China and Ireland.

TrumpRx.gov Platform

  • πŸ’» All discounted drugs will be available directly to consumers via TrumpRx.gov, with pricing to be launched before the end of the year.
  • βœ… The platform aims to provide consumers with deeply discounted prices, with many widely used drugs available for 60% off or more.
Knowledge graph37 entities Β· 38 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
37 entities
Chapters5 moments

Key Moments

Transcript43 segments

Full Transcript

Topics13 themes

What’s Discussed

Donald TrumpNovo NordiskEli LillyGLP-1 drugsZepboundWegovyDrug pricingMost Favored NationsMedicareMedicaidDomestic manufacturingTariffsTrumpRx.gov
Smart Objects37 Β· 38 links
CompaniesΒ· 9
LocationsΒ· 4
ProductsΒ· 9
PeopleΒ· 11
MediaΒ· 1
ConceptsΒ· 3